Assessing the impact of evolocumab on thin-cap fibroatheroma and endothelial function in patients with very high-risk atherosclerotic cardiovascular disease: a study protocol for a randomized controlled trial
All content on this site: Copyright © 2025 AME Publishing Company. All rights are reserved. For all open access content, the Creative Commons licensing terms apply.
Published by AME Publishing Company
Address: Flat/RM C 16F, Kings Wing Plaza 1, NO. 3 on Kwan Street, Shatin, NT, Hong Kong, China.
Email: editor@thecdt.org
Comments (0)